Using blue blocking glasses to improve mood and sleep in bipolar disorder
Stabilizing Mood and Sleep With Blue Blocking Eyewear in Bipolar Disorder
NA · Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital · NCT06271304
This study is testing whether wearing blue blocking glasses can help people with bipolar disorder feel more stable and sleep better during their manic or hypomanic phases.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (other) |
| Locations | 1 site (Copenhagen) |
| Trial ID | NCT06271304 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of blue blocking eyewear as an add-on treatment for patients with bipolar disorder experiencing hypomanic or manic phases. Participants will be randomized to receive either blue blocking glasses or low filtration glasses for a week, followed by a three-month period of daily use tailored to their mood state. The study includes electronic self-monitoring of mood, sleep, and activity, along with clinical assessments at various follow-up points. The aim is to determine if this intervention can stabilize mood and enhance sleep quality in individuals undergoing outpatient treatment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-60 with a diagnosis of bipolar disorder who are currently experiencing hypomanic or manic symptoms.
Not a fit: Patients with severe eye disorders, sleep disturbances unrelated to bipolar disorder, or those currently using beta-blockers may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could provide a non-pharmacological option for managing manic symptoms and improving sleep in patients with bipolar disorder.
How similar studies have performed: While the use of blue blocking eyewear is a novel approach in this context, similar interventions targeting light exposure have shown promise in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of bipolar disorder * YMRS-score \>13 * Age 18-60 years * Speaks and writes Danish at a level equal to mother tongue Exclusion Criteria: * Not willing or able to adhere to the protocol * Severe eye disorder or eye trauma * Treatment with betablockers * Sleep disturbances not related to BD (e.g, sleep apnea, restless legs syndrome) • • Substance abuse * Unwilling to use the electronic self-monitoring system, the Monsenso system * Prior/current use of BB glasses * Current/planned pregnancy * Night shift work * Suicidality
Where this trial is running
Copenhagen
- Psychiatric Center Copenhagen — Copenhagen, Denmark (RECRUITING)
Study contacts
- Principal investigator: Lars Kessing — Mental Health Center Copenhagen
- Study coordinator: Helle Madsen, MD
- Email: helle.oestergaard.madsen@regionh.dk
- Phone: 38 64 70 81
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Bipolar Disorder